| AANAT | Arylalkylamine-N-acetyltransferase |
| AMPKα | 5’Adenosine monophosphate-activated protein kinase |
| aPL | Antiphospholipid antibodies |
| BDNF | Brain-derived neurotrophic factor |
| BMP-2 | Bone morphogenetic protein 2 |
| BMPs | Bone morphogenetic proteins |
| CAT | Catalase |
| CRY | Cryptochrome |
| DD | Constant darkness |
| NK | Natural killer cell |
| E12 | Embryonic day 12 |
| E2 | 17β-Estradiol |
| E22 | Embryonic day 22 |
| EMS | Endometriosis |
| ERα | Estrogen receptor alpha |
| Gdf | Growth/differentiation factor |
| H/R | Hypoxia/reoxygenation |
| HB-EGF | Heparin binding-epidermal growth factor |
| hMTNR1B | Melatonin receptor 1B |
| Hox | Homeobox genes |
| Ihhi | P4-Regulated Indian Hedgehog |
| IL-11 | Interleukin 11 |
| IUGR | Intrauterine growth restriction |
| LD | Light–dark cycle |
| LIF | Leukemia inhibitory factor |
| MDA | Malondialdehyde |
| MMPs | Metalloproteinases |
| MR1A | Melatonin receptor 1A |
| MR1B | Melatonin receptor 1B |
| MT1 | Melatonin receptor 1 |
| MT2 | Melatonin receptor 2 |
| MT3 | Melatonin receptor 3 |
| NAS | N-acetylserotonin |
| NF-kB | Nuclear factor kappa B |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| P4 | Progesterone |
| PER | Period |
| Per1-luc | Period1-luciferase |
| PG | Prostaglandin |
| PI | Placental insufficiency |
| PRA | Progesterone receptor A |
| Ptgs2 | Prostaglandin G/H synthase 2 |
| ROCK1 | Coiled-coil containing protein kinases 1 |
| SCID | Severe combined immunodeficiency |
| SCN | Suprachiasmatic nucleus |
| sFlt-1 | Fms-like tyrosine kinase 1 |
| SOD | Superoxide dismutase |
| TGF-β | Transforming growth factor beta |
| UESCs | Uterus endometrial stromal cells |
| UP | Uterine peristalsis |
| VEGF | Vascular endothelial growth factor |